Synthesis of 5,6-Dimethyl-9-methoxy-1-phenyl-6H-pyrido[4,3-b]carbazole derivatives and their cytotoxic activity

Archiv der Pharmazie

Volumn 338, Issue 11, 2005, Pages 556-561

  Jasztold Howorko, Ryszard ^a   Pelczynska, Marzena ^b   Nasulewicz, Anna ^b   Wietrzyk, Joanna ^b   Opolski, Adam ^b,c  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^c JAN DLUGOSZ UNIVERSITY   (Poland)

Author keywords

1 Substituted 6H pyrido 4,3 b carbazole; Cytotoxicity; Olivacine

Indexed keywords

CARBAZOLE DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SUBSTITUTION REACTION;

ANTINEOPLASTIC AGENTS; CARBAZOLES; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INHIBITORY CONCENTRATION 50; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 28544439149     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200500141     Document Type: Article

References (12)

1. C. Atasi, P. Dumont, O. Pepin, O. Gros, P. Gros, Proc. Am. Assoc. Cancer Res. 1989, 30, 617.
2. S. Modi, T. McComb, A.-H. Zayed, R. C. Oglesby, S. Archer, Tetrahedron 1990, 46, 5555-5562.
3. P. Juret, J. F. Heron, J. E. Couette, T. Delozier, J. Y. Le Taaler, Cancer Treat. Rep. 1982, 66, 1909-1916.
4. R. Jasztold-Howorko, C. Landras, A. Pierré, G. Atassi, N. Guilbaud, L. Kraus-Bertier, S. Léonce, Y. Rolland, J.-F. Prost, E. Bisagni, J. Med. Chem. 1994, 37, 2445-2452.
5. S. Le Mée, A. Pierré, J. Markovits, G. Atassi, A. Jacquemin-Sablon, J.-M. Saucier, Mol. Pharmacol. 1998, 53, 213-220.
6. C. Landras, R. Jasztold-Howorko, A. Pierré, S. Léonce, N. Guilbaud, L. Kraus-Bertier, C. Guillonneau, Y. Rolland, G. Atassi, E. Bisagni, Chem. Pharm. Bull. 1996, 44, 2169-2172.
7. R. Jasztold-Howorko, A. Croisy, D. Carrez, I. Jaroszewicz, A. Nasulewicz, M. Pełczyńska, A. Opolski, Arch. Pharm. Pharm. Med. Chem. 2004, 337, 599-604.
8. A. Romaniewska, R. Jasztold-Howorko, A. Regiec, T. Lis, J. Kuduk-Jaworska, Eur. J. Inorg. Chem. 2003, 22, 4043-4054.
9. C. W. Mosher, O. P. Crews, E. M. Acton, L. Goodman, J. Med. Chem. 1966, 9, 237-241.
10. D. Pelaprat, R. Oberlin, I. Le Guen, B. P. Roques, J.-B. Le Pecq, J. Med. Chem. 1980, 23, 1330-1335.
11. R. I. Geran, N. H. Greenberg, M. M. MacDonald, A. M. Schumacher, B. D. Abbott, Cancer Chemotherapy Reports, 1972, 3, 2 (part 3): 59-61.
12. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. Mcmahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, M. R. Boyol, J. Natl. Cancer Inst. 1990, 82, 1107.